TABLE 3.
Variables | Ischemic stroke
|
Hemorrhagic stroke
|
---|---|---|
AHR (95% CI) | AHR (95% CI) | |
HIV infection | 1.33 (1.09–1.63)** | 2.01 (1.51–2.69)*** |
Demographics | ||
Age, yr | ||
15–49 | 1 | 1 |
≥50 | 7.63 (6.32–9.22)*** | 3.95 (2.83–5.50)*** |
Sex | ||
Male | 1 | 1 |
Female | 0.79 (0.62–1.00)* | 0.57 (0.37–0.88)* |
Income level | ||
Low | 2.15 (1.67–2.75)*** | 2.11 (1.40–3.19)*** |
Intermediate | 1.26 (0.95–1.66) | 1.78 (1.14–2.77)* |
High | 1 | 1 |
Urbanization | ||
Rural | 1 | 1 |
Urban | 0.95 (0.80–1.12) | 0.84 (0.64–1.10) |
Comorbidities | ||
Diabetes | 2.28 (1.70–3.07)*** | 0.55 (0.24–1.25) |
CKD | 1.59 (0.90–2.81) | 4.26 (1.98–9.19)*** |
HTN | 2.15 (1.65–2.81)*** | 3.41 (2.17–5.37)*** |
CHD | 1.53 (1.07–2.19)* | 0.28 (0.08–0.94)* |
Dyslipidemia | 0.92 (0.62–1.37) | 1.32 (0.67–2.61) |
Cancer | 1.10 (0.67–1.82) | 2.27 (1.23–4.19)** |
SLE | 1.96 (0.74–5.15) | 1.73 (0.38–7.97) |
<.05;
<.01;
<.001
SD, standard deviation; AHR, adjusted hazard ratio; CI, confidence interval; HIV, human immunodeficiency virus; CKD, chronic kidney disease; HTN, hypertension; CHD, coronary heart disease; SLE, systemic lupus erythematous.